Advanced Peptide Therapies

Research Peptides

Cutting-edge peptide therapies for metabolism, recovery, and cellular optimization. These advanced treatments are designed to support your body's natural healing and performance systems.

Prescription Medications Require Medical Clearance: All prescription medications, peptides, and hormone therapies require a comprehensive medical evaluation, diagnosis, and prescription by a licensed healthcare provider. These are Schedule III-V controlled substances or prescription-only medications that can only be dispensed with a valid prescription from a licensed provider. Our medical team will review your medical history, current medications, and health conditions to determine if treatment is safe and appropriate for you. No prescription will be issued without proper medical clearance and ongoing monitoring.

State Licensing & Telemedicine Services: TruCare Health providers are licensed in California and select states where we offer telemedicine services. Dr. Uzma Ahmed (Medical Director) holds California Medical License A168567. All providers maintain active, unrestricted licenses in good standing. You must be physically located in a state where our providers are licensed during your consultation. For verification of provider licenses and states served, visit our Licensing & Compliance page.

Medical Necessity & Patient Safety: These treatments are not suitable for all individuals. Qualification is determined based on comprehensive medical evaluation including medical history, current health status, laboratory results (when required), contraindications, drug interactions, and provider medical judgment. Not all patients will be approved for treatment. Treatments may be contraindicated in patients with certain medical conditions, pregnant or nursing women, or those taking certain medications. Your provider will discuss all risks, benefits, and alternatives before prescribing any medication.

No Guarantees - Results Vary: Individual results vary significantly and are not guaranteed. Outcomes depend on multiple factors including adherence to treatment protocols, lifestyle modifications (diet, exercise, sleep), underlying health conditions, genetics, age, and individual physiological response to treatment. The results and statistics shown represent clinical study averages or typical patient outcomes and may not reflect your personal experience. Some patients may experience better results, some may experience less benefit, and some may not respond to treatment at all. Continued medical supervision is required throughout treatment.

FDA Status & Compounded Medications: Some medications offered are FDA-approved for specific indications and may be prescribed off-label for other conditions based on medical judgment and evidence. Compounded medications are prepared by licensed compounding pharmacies and are not FDA-approved but are legal when prescribed by licensed providers for individual patient needs. Your provider will discuss the FDA status and evidence supporting any prescribed treatment.

Advertising Compliance & Clinical Evidence: All treatment claims and statistics presented are based on published clinical studies, FDA approval data, or manufacturer information. Individual results may differ significantly from study averages. References to clinical studies and research are provided where available. Statistics reflect controlled study conditions and may not be representative of typical patient outcomes. Not all uses mentioned are FDA-approved; some represent off-label uses supported by medical evidence and provider judgment. Citations and study details are available upon request.

Advanced Peptide Research

Our research peptide program offers access to cutting-edge therapies that target specific biological pathways for metabolism, recovery, and cellular health. Each peptide is carefully selected based on emerging clinical evidence and administered under medical supervision as part of a comprehensive wellness program.

GHK-Cu Peptide

Advanced Aesthetic Peptide

How It Works

Copper peptide that stimulates collagen and elastin production while acting as an antioxidant and anti-inflammatory

Protocol

•Subcutaneous injection (5 days on, 2 days off)
•Start: 2mg
•Dosage increase options: As directed by the provider based on clinical response
•Injection sites: Rotate between abdomen, thigh, or upper arm
•Protocol may be adjusted based on medical provider expertise

Key Benefits

•May support skin appearance/quality as part of a broader skincare routine
•Easy to bundle with hydration, sleep, sun habits, and topical care
•Weekday cadence supports consistent routines and check-ins
•Pairs well with cosmetic-focused wellness packages
•Promotes skin regeneration
•Reduces appearance of wrinkles
•Enhances wound healing
•Improves skin firmness

Clinical Evidence

•In vitro studies demonstrated increased collagen type I synthesis and stimulation of fibroblast proliferation
•Published research in the International Journal of Cosmetic Science showed improved wound healing and skin remodeling properties
•Clinical observations report enhanced skin appearance with reduced fine lines over 12 weeks of consistent use

Based on laboratory and clinical studies; individual aesthetic results may vary based on skin type and overall skincare routine

Important Safety Information

Do Not Use If:

✕Wilson's disease or other copper-handling/metabolism disorders
✕Known allergy or hypersensitivity to copper compounds or excipients
✕Pregnancy and breastfeeding (insufficient safety data)

Use With Caution:

⚠Significant liver disease (copper is hepatically handled)
⚠Active cancer—route to prescribing provider for risk/benefit decision

Side Effects:

•Generally well-tolerated when used as directed
•Mild injection site reactions may occur
•Consult healthcare provider if any adverse effects occur

AOD-9604 Peptide

Advanced peptide therapy for fat metabolism and body composition

How It Works

AOD-9604 is a modified fragment of human growth hormone specifically designed to stimulate fat breakdown while preserving lean muscle mass. It works by mimicking the way natural growth hormone regulates fat metabolism.

Protocol

•Subcutaneous injection (5 days on, 2 days off)
•Start: 240mcg
•Dosage increase options: As directed by the provider based on clinical response
•Injection sites: Rotate between abdomen, thigh, or upper arm
•Take in the morning on an empty stomach
•Protocol may be adjusted based on medical provider expertise

Key Benefits

•Morning routine that may support fat-loss efforts as part of a full program
•Non-stimulant positioning; pairs well with protein and walking goals
•Helps reinforce daily habits and tracking Monday–Friday
•Fits easily into 30-, 60-, and 90-day body-comp plans
•Supports lean muscle preservation
•Enhances energy utilization

Clinical Evidence

•Phase II clinical trials demonstrated body fat reduction without adverse metabolic effects on glucose or lipid metabolism
•Human studies showed selective fat-reducing effects in abdominal region with preservation of lean mass
•Safety profile established in clinical trials with no significant adverse events related to treatment

Based on clinical trial data; fat metabolism effects observed in controlled studies, individual body composition results vary with diet and exercise adherence

Important Safety Information

Do Not Use If:

✕Known allergy or hypersensitivity to AOD-9604 or components
✕Active cancer or history of GH-sensitive tumors unless cleared by prescribing provider
✕Pregnancy and breastfeeding (not studied in these populations)

Use With Caution:

⚠Diabetes or insulin resistance (monitor glucose if on antidiabetic therapy)
⚠Thyroid dysfunction (optimize/monitor)
⚠History of edema or sleep apnea (fluid shifts may worsen symptoms)

Side Effects:

•Generally well-tolerated in clinical studies
•Mild injection site reactions may occur
•Monitor for fluid retention in susceptible individuals

MOTS-C Peptide

Mitochondrial-derived peptide for cellular energy and metabolic optimization

How It Works

MOTS-c is a mitochondrial-derived peptide that regulates metabolic function by improving cellular energy production. It enhances the body's ability to process glucose and supports overall metabolic health and longevity.

Protocol

•Once weekly subcutaneous injection
•Start: 500mcg
•Dosage increase options: As directed by the provider based on clinical response
•Injection sites: Rotate between abdomen, thigh, or upper arm
•Protocol may be adjusted based on medical provider expertise

Key Benefits

•May support energy and metabolic wellness alongside nutrition and activity
•Weekly dosing makes adherence simple for busy clients
•Can help clients feel more capable of doing the basics (steps, lifts, meal prep)
•Works well in Metabolic Kickstart bundles with coaching
•Enhances mitochondrial function and energy production
•Supports healthy aging at the cellular level

Clinical Evidence

•Research published in Cell Metabolism demonstrated improved insulin sensitivity and glucose regulation with MOTS-c administration
•Animal studies showed enhanced exercise capacity and metabolic flexibility with peptide treatment
•Emerging clinical research indicates potential benefits for age-related metabolic decline

Evidence primarily from preclinical and early-phase human studies; metabolic optimization effects being investigated in ongoing clinical research

Important Safety Information

Do Not Use If:

✕Known allergy or hypersensitivity to MOTS-C or components
✕Pregnancy and breastfeeding (insufficient human safety data)

Use With Caution:

⚠Active cancer or unclear cancer history—route to prescribing provider
⚠Concomitant metabolic agents (e.g., strong AMPK-modulating drugs); provider to monitor and decide

Side Effects:

•Generally well-tolerated in clinical studies
•Minimal side effects reported
•Consult healthcare provider if any adverse effects occur

BPC 157/TB 500

A peptide combination therapy designed to support recovery and tissue repair alongside rehabilitation and training programs.

How It Works

BPC 157/TB 500 is a peptide combination that may support tissue repair and recovery processes. This therapy is designed to complement rehabilitation programs, smart training protocols, and load management strategies.

Protocol

•Subcutaneous injection (5 days on 2 days off)
•5x/week dosing schedule
•Start: 600mcg/600mcg
•Dosage increase options: As directed by the provider based on clinical response
•Injection sites: Injury region or standard SC sites; rotate regularly
•Protocol may be adjusted based on medical provider expertise

Key Benefits

•Positioned for recovery support alongside rehab, smart training, and load management
•May help clients stay consistent with their plan (sleep, mobility, physical therapy)
•Five-day cadence supports routine and weekly progress reviews
•Fits naturally into 'Recovery Support' packages with coaching
•Supports tissue repair and recovery processes

Clinical Evidence

•BPC-157 demonstrated accelerated healing in animal models of tendon and ligament injuries (Journal of Physiology and Pharmacology)
•TB-500 (Thymosin Beta-4) shown to promote cell migration and tissue regeneration in wound healing research
•Combined peptide therapy investigated in sports medicine for recovery support, with observational reports of improved healing timelines

Evidence primarily from animal studies and observational clinical use; human clinical trials limited, tissue repair support best combined with proper rehabilitation protocols

Important Safety Information

Do Not Use If:

✕Known allergy or hypersensitivity to peptide components
✕Active cancer (avoid peptides with potential pro-repair/angiogenic signaling unless specialist-cleared)
✕Pregnancy and breastfeeding (insufficient human safety data)

Use With Caution:

⚠Autoimmune disease or patients on potent immunomodulators—provider to decide
⚠History of unusual wound-healing disorders—provider to decide

Side Effects:

•Injection site reactions
•Mild fatigue
•Temporary discomfort at injection site

Ready to Explore Peptide Therapy?

Schedule a consultation with our medical team to discuss whether peptide therapy is right for your wellness goals. All treatments are administered under medical supervision.